Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-23-006820)

Filing Details

Accession Number:: 0001225208-23-006820
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-06-14 16:19:45
Reporting Period:: 2023-06-12

Accepted Time:: 2023-06-14 16:19:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
200406	Johnson & Johnson	JNJ	Pharmaceutical Preparations (2834)	221024240

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1745955	E Kathryn Wengel	One Johnson &Amp; Johnson Plaza New Brunswick NJ 08933	Evp, Chief To And Risk Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-06-12	12,465	$160.00	65,934	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	59	Indirect	By 401k
Common Stock	281	Indirect	By ESOP

Footnotes

Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (5/30/2023).
Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (5/30/2023).